Jump to content

Approach to Oligometastatic Prostate Cancer -ASCO 2016

Paul Edwards

Recommended Posts

"There are differing schools of thoughts regarding whether oligometastases represent isolated lesions—where targeted therapy may render a patient disease free—or whether they coexist with micrometastases, where targeted therapy in addition to systemic therapy is required for maximal clinical impact.   As such, the approach to the patient with oligometastatic prostate cancer requires multidisciplinary consideration, with surgery, radiotherapy, and systemic therapy potentially of benefit either singularly or in combination.  Indeed, mounting evidence suggests durable disease-free intervals and, in some cases, possibly cure, may be achieved with such a multimodal strategy.   However, selecting patients that may benefit most from treatment of oligometastases is an ongoing challenge. "


Click on this link to read a paper on oligometastatic prostate cancer from the 2016 American Society of Clinical Oncology (ASCO) Scientific Meeting.



Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...